A new University of Manchester analysis identifies three essential problems with current therapy evaluation methods that clinicians and patients should understand. First, research standards designed for pharmaceutical drugs inadequately assess talking treatments, which operate through fundamentally different mechanisms. Second, randomized controlled trials struggle to account for the therapist-patient relationship and individual treatment variations that drive therapeutic success. Third, alternative research approaches exist that could more accurately capture therapy effectiveness and lead to improved patient outcomes. These gaps have significant implications: patients may be denied access to genuinely effective treatments, and mental health service design may be distorted by flawed evidence standards. The analysis calls for research methodology to evolve beyond pharmaceutical frameworks, enabling more accurate evaluation of psychological interventions and supporting better clinical decision-making.
Was this article helpful?
